Complexation with polymeric excipient for improved water solubility

On the one hand, better water solubility of drugs leads to an improved bioavailability. Secondly, drug concentration for application can be decreased.

At Saarland University, a procedure has been developed that allows a significant enhancement of water solubility of compounds that are usually insoluble. The method combines the advantages of both known approaches – without showing their disadvantages. This can be attained by reversible complex formation of the active agents with a certain structural element which is approved for oral application. But simple blending of both components does not lead to an improved solubility. Only a combination of complex formation and freeze drying finally results in products that are water soluble. This approach allows it to produce active agent complexes showing an increased water solubility using standard procedures and prevalent chemicals.

Further Information: PDF

Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-6340

Contact
Dr. Annekathrin Seifert (Dipl.-Chem.), Dipl.-Kfm. Axel Koch (MBA), Dr. Hauke Studier (Dipl.-Phys.)

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Recovering phosphorus from sewage sludge ash

Chemical and heat treatment of sewage sludge can recover phosphorus in a process that could help address the problem of diminishing supplies of phosphorus ores. Valuable supplies of phosphorus could…

Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids

EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…

After 25 years, researchers uncover genetic cause of rare neurological disease

Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…

Partners & Sponsors